Source: Υπουργείο Υγείας (CY) Revision Year: 2021 Publisher: MEDOCHEMIE LTD, 1-10 Constantinoupoleos street, 3011 Limassol, Cyprus
Magrilan 20mg capsules.
| Pharmaceutical Form |
|---|
|
Hard capsule. Yellow-violet hard gelatine capsules, size “4”. |
Each Magrilan 20mg capsule contains fluoxetine hydrochloride equivalent to 20mg of fluoxetine base.
Excipients with known effect: lactose monohydrate, sunset yellow.
Each 20 mg capsule contains 105.0 mg lactose monohydrate and 0.0024 mg sunset yellow.
For the full list of excipients see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Fluoxetine |
Fluoxetine is a selective inhibitor of serotonin reuptake, and this probably accounts for the mechanism of action. Fluoxetine has practically no affinity to other receptors such as α1 |
| List of Excipients |
|---|
|
Violet/Yellow capsules: Lactose monohydrate Capsule shell consisting of sunset yellow FCF (E110), titanium dioxide (E171), iron oxide yellow (E172), brilliant blue FCF (E133), erythrosine (E127) and gelatin. |
PVC Al blisters. Boxes of 10, and 30 capsules.
Not all pack sizes may be marketed.
MEDOCHEMIE LTD, 1-10 Constantinoupoleos street, 3011 Limassol, Cyprus
19891
Date of first authorization: 28/12/2005
Date of Renewal of the Authorisation: 14/09/2011
| Drug | Countries | |
|---|---|---|
| MAGRILAN | Cyprus, Hong Kong, Lithuania, Malta, Romania, Singapore |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
